Gilead Sciences (GILD) Stock: What to Know Before the Market Opens on December 22, 2025

Gilead Sciences (GILD) Stock: What to Know Before the Market Opens on December 22, 2025

Ahead of the U.S. market open on Monday, December 22, 2025 (the next trading session after Friday’s close), Gilead Sciences, Inc. (NASDAQ: GILD) is in focus for two reasons that matter to both short-term traders and long-term investors: a new U.S. government drug-pricing agreement that could reshape near-term sentiment across big pharma, and fresh late-stage HIV pipeline success that reinforces Gilead’s core franchise heading into 2026. Gilead+1 Below is a market-ready briefing—current catalysts, what analysts are watching, key numbers, and the biggest risks—written for readers looking to understand what could move GILD stock as the bell approaches. GILD stock snapshot
Chevron (CVX) Stock: What to Know Before the Market Opens on Dec. 22, 2025

Chevron (CVX) Stock: What to Know Before the Market Opens on Dec. 22, 2025

Chevron Corporation (NYSE: CVX) heads into the Dec. 22, 2025 U.S. market open with investors balancing three big forces: (1) fresh geopolitics around Venezuela and global crude flows, (2) natural gas growth catalysts in the Eastern Mediterranean, and (3) Chevron’s own post-Hess playbook—higher output, disciplined spending, and heavier cost-cutting. Below is a practical, news-driven primer on what matters most for Chevron stock before the bell—including the latest headlines, upcoming catalysts, and where Wall Street’s forecasts cluster. Chevron stock snapshot heading into the open What this means into Monday: CVX is trading more like a “macro + oil tape” stock than
IBM Stock Preview for Dec. 22, 2025: Confluent Deal, Analyst Targets, Dividend Outlook, and Key Catalysts Before the Opening Bell

IBM Stock Preview for Dec. 22, 2025: Confluent Deal, Analyst Targets, Dividend Outlook, and Key Catalysts Before the Opening Bell

International Business Machines Corporation (NYSE: IBM) heads into the Dec. 22 U.S. market open with investors balancing a blockbuster acquisition headline, ongoing AI-and-hybrid-cloud momentum, and the realities of holiday-thinned trading. IBM finished the latest session at $300.98 with modest gains on the day and volume around 11.0 million shares, leaving the stock near a psychologically important $300 level as the week begins. Below is what matters most for IBM stock before the opening bell on Dec. 22, 2025—including the biggest headlines, what Wall Street forecasts imply from here, and the events that could shape the next move. IBM stock price
Insmed (INSM) Stock: What to Know Before the Market Opens on Dec. 22, 2025

Insmed (INSM) Stock: What to Know Before the Market Opens on Dec. 22, 2025

Insmed Incorporated (NASDAQ: INSM) heads into the Monday, Dec. 22, 2025 session with two powerful—almost opposing—forces in play: a fresh clinical disappointment that jolted sentiment last week, and a major index catalyst that can drive mechanical buying at the open. Shares last closed at $174.84 (up about 5% on the day) after an exceptionally volatile week for the biotech, with after-hours trading roughly flat. StockAnalysis Below is what investors and traders typically want on their radar before the bell. The biggest catalyst for Monday: Insmed joins the Nasdaq-100 before the open Insmed is scheduled to be added to the Nasdaq-100
Lululemon (LULU) stock: What to know before the market opens on Dec. 22, 2025

Lululemon (LULU) stock: What to know before the market opens on Dec. 22, 2025

U.S. stocks reopen after the weekend at 9:30 a.m. ET on Monday, Dec. 22, 2025—and lululemon athletica inc. (NASDAQ: LULU) is one of the most closely watched retail names heading into the holiday-shortened week. Trading conditions can also get choppier as liquidity thins into Christmas: the NYSE and Nasdaq are scheduled to close early at 1:00 p.m. ET on Wednesday, Dec. 24, 2025, and markets will be closed on Thursday, Dec. 25. Kiplinger+1 What’s driving the attention isn’t just holiday demand. Lululemon is navigating a rare combination of CEO succession, activist investor pressure, and a tariff/de minimis cost headwind that
Texas Instruments (TXN) Stock: Latest News, Analyst Forecasts, and What to Watch Before the Market Opens on Dec. 22, 2025

Texas Instruments (TXN) Stock: Latest News, Analyst Forecasts, and What to Watch Before the Market Opens on Dec. 22, 2025

Texas Instruments Incorporated (NASDAQ: TXN) heads into the U.S. market open on Monday, December 22, 2025 with investors weighing two forces that can pull the stock in opposite directions: long-term manufacturing expansion (including a fresh U.S. production milestone in Sherman, Texas) and near-term caution around demand, margins, and analyst sentiment. As of the latest available trade data, TXN was around $176.29 (last session range roughly $175.95–$178.19). Below is what matters most for anyone watching Texas Instruments stock before the opening bell. 1) The biggest new headline: TI starts production at its newest Sherman, Texas 300mm fab (SM1) In a major
T-Mobile Stock (TMUS) Before Market Open Dec. 22, 2025: Latest News, Buyback Plans, Legal Risks, and Analyst Forecasts

T-Mobile Stock (TMUS) Before Market Open Dec. 22, 2025: Latest News, Buyback Plans, Legal Risks, and Analyst Forecasts

Ahead of the next U.S. stock market open on Monday, December 22, 2025, investors in T-Mobile US, Inc. (NASDAQ: TMUS) have plenty to digest: a newly authorized $14.6 billion shareholder return program, an escalating legal fight with AT&T tied to T-Mobile’s new “switching” tools, and ongoing questions about wireless growth as promotions intensify across the industry. TMUS ended the most recently reported regular session at $196.73 (down 1.77%) and remained well below its 52‑week high of $276.49 reached earlier this year, with trading volume notably elevated versus its recent average. MarketWatch What matters most for TMUS right now TMUS stock
Wells Fargo Stock (WFC): What to Know Before the U.S. Market Opens on Dec. 22, 2025

Wells Fargo Stock (WFC): What to Know Before the U.S. Market Opens on Dec. 22, 2025

Wells Fargo & Company (NYSE: WFC) heads into Monday’s Dec. 22 session with momentum from a strong 2025 run, but also with a long checklist of catalysts investors are tracking: an investment-banking push that’s changing the revenue mix, ongoing expense and headcount reshaping tied to AI, capital return (dividends and buybacks), and the post–asset-cap era that has re-opened the conversation about growth and returns. Because this is a holiday-shortened week (early close Dec. 24 and closed Dec. 25), trading volumes can thin out—sometimes amplifying moves on headlines, analyst notes, or rate swings. MarketWatch+2nyse.com+2 Below is a detailed, pre-market guide to
UnitedHealth (UNH) Stock: Key Audit Updates, DOJ Risks, Earnings Outlook and Analyst Forecasts Before the Market Opens Dec. 22, 2025

UnitedHealth (UNH) Stock: Key Audit Updates, DOJ Risks, Earnings Outlook and Analyst Forecasts Before the Market Opens Dec. 22, 2025

UnitedHealth Group Incorporated (NYSE: UNH) heads into the Monday, Dec. 22, 2025 U.S. market open with investors balancing a fresh company-led audit update against a busy regulatory and legal backdrop spanning Medicare Advantage, Optum Rx, and ongoing litigation. Friday’s close also sets the tone: UNH ended the last regular session at $327.42 after trading between roughly $326 and $335, with about 10.6 million shares changing hands. Yahoo Finance This is also a holiday-shortened stretch for markets. NYSE and Nasdaq are scheduled to close early on Wednesday, Dec. 24, and be closed on Thursday, Dec. 25 (Christmas Day)—conditions that can thin
Rocket Lab (RKLB) Stock: Space Force Satellite Deal, Record Electron Launches, Neutron Timeline, and Wall Street Forecasts Ahead of the Dec. 22, 2025 Market Open

Rocket Lab (RKLB) Stock: Space Force Satellite Deal, Record Electron Launches, Neutron Timeline, and Wall Street Forecasts Ahead of the Dec. 22, 2025 Market Open

Ahead of the U.S. stock market open on Monday, December 22, 2025, Rocket Lab Corporation (Nasdaq: RKLB) is back in the spotlight after a cluster of news catalysts that hit within days: a landmark U.S. Space Development Agency (SDA) award tied to missile warning satellites, a high-tempo stretch of launches for national security customers, and fresh focus on the company’s next major growth step—Neutron, its reusable medium-lift rocket. What matters now for investors is separating headline-driven momentum from the operational and financial realities that will determine whether Rocket Lab can “grow into” its valuation through 2026 and beyond—especially in a
Strategy Inc (MSTR) Stock: What to Know Before the Market Opens on Dec. 22, 2025

Strategy Inc (MSTR) Stock: What to Know Before the Market Opens on Dec. 22, 2025

Strategy Inc (NASDAQ: MSTR)—the company formerly known as MicroStrategy—heads into the Dec. 22, 2025 U.S. session as one of the market’s most closely watched “Bitcoin proxy” equities. The setup is unusually headline-driven right now: fresh Bitcoin purchases, capital-raise/dilution dynamics, index-related flow risks, and company guidance that can swing wildly with Bitcoin’s year-end price. As of the latest available trade data, MSTR closed at $164.82, while Bitcoin traded around $88,633. Below is what matters most for investors before the opening bell. The fastest takeaways for Dec. 22 First, “Strategy Inc” in plain English Strategy completed a rebrand and legal name change
Warner Bros. Discovery (WBD) Stock: Netflix Deal, Paramount Bid, and Key Numbers to Watch Before the Market Opens on Dec. 22, 2025

Warner Bros. Discovery (WBD) Stock: Netflix Deal, Paramount Bid, and Key Numbers to Watch Before the Market Opens on Dec. 22, 2025

Warner Bros. Discovery, Inc. – Series A (NASDAQ: WBD) heads into the Dec. 22, 2025 market open in an unusually binary spot: the stock is being pulled less by day-to-day operating performance and more by a fast-moving takeover battle that now involves Netflix and Paramount Skydance. As of the latest available trade, WBD was around $27.77 per share. That level matters because it’s essentially where the Netflix deal value has been framed—while Paramount is publicly pitching a higher $30 all-cash alternative. Below is what investors and readers should know heading into Monday’s open—what’s new, what Wall Street is debating, and

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Go toTop